Loading company…
Washington-based biopharmaceutical company developing tissue-targeted therapeutics for cancer, fibrosis and infectious diseases.
Founded in 2016 and based in Washington, US, Silverback Therapeutics, Inc. develops tissue-targeted therapeutics. Its programs address patients with cancer, fibrosis and other infectious diseases. The company is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in